Newcastle University has announced details of a £200 million programme of investment in its campus and facilities.

A pain-free and drug-free labour may be many expectant mothers’ dream but researchers reveal that reality hits hard.

The first UK trial of a new drug which targets the DNA repair mechanism in people with hereditary forms of breast or ovarian cancer, is being started by Newcastle University scientists working for the charity, Cancer Research UK.

Despite advances in prevention, acute care, and rehabilitation, 20-30% of patients in the UK die within a month of having a stroke and 13% of survivors are discharged to institutional care, according to experts in this week’s British Medical Journal.